Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Published in: Journal of Nuclear Cardiology 3/2011

01-05-2011 | ASNC Information Statement

Strategies for defining an optimal risk-benefit ratio for stress myocardial perfusion SPECT

Authors: Reza Fazel, MD, MSc, Vasken Dilsizian, MD, Andrew J. Einstein, MD, PhD, Edward P. Ficaro, PhD, Milena Henzlova, MD, Leslee J. Shaw, PhD

Published in: Journal of Nuclear Cardiology | Issue 3/2011

Login to get access

Excerpt

Tremendous growth in medical imaging has prompted a re-focusing on the appropriateness of testing and the rationale for exposure to ionizing radiation for large segments of the adult population at intermediate to high likelihood for coronary artery disease (CAD).1-9 Part I of this series addressed the technical or methodological approaches to measuring radiation exposure and laboratory approaches to reducing exposure including the clinical utility of stress only imaging.10 In the current statement, we present a clinical approach for defining the risk:benefit ratio of myocardial perfusion imaging (MPI) focusing on the appropriate use of single photon-emission computed tomography (SPECT) or positron emission tomography (PET) MPI. We also review the concept of “patient-centered imaging” and discuss methods for effectively addressing patient concerns regarding procedural risk. …
Literature
1.
Shaw LJ, Marwick TH, Zoghbi WA, et al. Why all the focus on cardiac imaging? JACC Cardiovasc Imaging 2010;3:789-94.PubMedCrossRef
2.
Shaw LJ, Achenbach S, Chandrashekhar Y, et al. Imaging modalities and radiation: Benefit has its risks. JACC Cardiovasc Imaging 2010;3:550-2.PubMedCrossRef
3.
Gerber TC, Gibbons RJ. Weighing the risks and benefits of cardiac imaging with ionizing radiation. JACC Cardiovasc Imaging 2010;3:528-35.PubMedCrossRef
4.
Laskey WK, Feinendegen LE, Neumann RD, Dilsizian V. Low-level ionizing radiation from noninvasive cardiac imaging: Can we extrapolate estimated risks from epidemiologic data to the clinical setting? JACC Cardiovasc Imaging 2010;3:517-24.PubMedCrossRef
5.
Chen J, Einstein AJ, Fazel R, et al. Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: A population-based analysis. J Am Coll Cardiol 2010;56:712-4.CrossRef
6.
Fazel R, Krumholz HM, Wang Y, et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009;361:849-57.PubMedCrossRef
7.
Einstein AJ. Radiation risk from coronary artery disease imaging: How do different diagnostic tests compare? Heart 2008;94:1519-21.PubMedCrossRef
8.
Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. J Am Med Assoc 2007;298:317-23.CrossRef
9.
Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ. Radiation dose to patients from cardiac diagnostic imaging. Circulation 2007;116:1290-305.PubMedCrossRef
10.
Cerqueira MD, Allman KC, Ficaro EP, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol 2010;17:709-18.PubMedCrossRef
11.
Kim KP, Einstein AJ, Berrington de Gonzalez A. Coronary artery calcification screening: Estimated radiation dose and cancer risk. Arch Intern Med 2009;169:1188-94.PubMedCrossRef
12.
Olson MB, Shaw LJ, Kaizar EE, et al. Obesity distribution and reproductive hormone levels in women: A report from the NHLBI-sponsored WISE study. J Womens Health (Larchmt) 2006;15:836-42.CrossRef
13.
Berrington de Gonzalez A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009;169:2071-7.PubMedCrossRef
14.
Einstein AJ, Weiner SD, Bernheim A, et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. J Am Med Assoc 2010;304:2137-44.CrossRef
15.
Shaw LJ, Taylor A, Raggi P, Berman DS. Role of noninvasive imaging in asymptomatic high-risk patients. J Nucl Cardiol 2006;13:156-62.PubMed
16.
National Research Council. Health risks from exposure to low levels of ionizing radiation: BEIR VII—Phase 2. Washington, DC: The National Academies Press; 2006.
17.
Brenner DJ, Doll R, Goodhead DT, et al. Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know. Proc Natl Acad Sci USA 2003;100:13761-6.PubMedCrossRef
18.
Little MP, Wakeford R, Tawn EJ, Bouffler SD, Berrington de Gonzalez A. Risks associated with low doses and low dose rates of ionizing radiation: Why linearity may be (almost) the best we can do. Radiology 2009;251:6-12.PubMedCrossRef
19.
Shaw LJ, Heller GV, Casperson P, et al. Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration cstudy no. 424. J Nucl Cardiol 2006;13:685-98.PubMedCrossRef
20.
Valentin J. Low-dose extrapolation of radiation-related cancer risk. Ann ICRP 2005;35:1-140.
21.
Berrington de Gonzalez A, Kim K-P, Smith-Bindman R, McAreavey D. Myocardial perfusion scans: Projected population cancer risks from current levels of use in the United States. Circulation 2010;122:2403-10.PubMedCrossRef
22.
23.
Senthamizhchelvan S, Bravo PE, Esaias C, et al. Human biodistribution and radiation dosimetry of 82Rb. J Nucl Med 2010;51:1592-9.PubMedCrossRef
24.
Einstein AJ, Elliston CD, Arai AE, et al. Radiation dose from single-heartbeat coronary CT angiography performed with a 320-detector row volume scanner. Radiology 2010;254:698-706.PubMedCrossRef
25.
Einstein AJ, Wolff SD, Manheimer ED, et al. Comparison of image quality and radiation dose of coronary computed tomographic angiography between conventional helical scanning and a strategy incorporating sequential scanning. Am J Cardiol 2009;104:1343-50.PubMedCrossRef
26.
Berman DS, Kang X, Tamarappoo B, et al. Stress thallium-201/rest technetium-99m sequential dual isotope high-speed myocardial perfusion imaging. JACC Cardiovasc Imaging 2009;2:273-82.PubMedCrossRef
27.
Einstein AJ, Sanz J, Dellegrottaglie S, et al. Radiation dose and cancer risk estimates in 16-slice computed tomography coronary angiography. J Nucl Cardiol 2008;15:232-40.PubMedCrossRef
28.
Duvall WL, Croft LB, Godiwala T, Ginsberg E, George T, Henzlova MJ. Reduced isotope dose with rapid SPECT MPI imaging: Initial experience with a CZT SPECT camera. J Nucl Cardiol 2010;17:1009-14.PubMedCrossRef
29.
Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging. Circulation 2009;119:e561-87.PubMedCrossRef
30.
Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639-47.PubMedCrossRef
31.
Ward RP, Al-Mallah MH, Grossman GB, et al. American Society of Nuclear Cardiology review of the ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI). J Nucl Cardiol 2007;14:e26-38.PubMedCrossRef
32.
Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665-70.PubMedCrossRef
33.
Shaw LJ, Berman DS, Blumenthal RS, et al. Clinical imaging for prevention: Directed strategies for improved detection of presymptomatic patients with undetected atherosclerosis—Part I: Clinical imaging for prevention. J Nucl Cardiol 2008;15:e6-19.PubMedCrossRef
34.
Beach MC, Roter DL, Wang NY, Duggan PS, Cooper LA. Are physicians’ attitudes of respect accurately perceived by patients and associated with more positive communication behaviors? Patient Educ Couns 2006;62:347-54.PubMedCrossRef
35.
Sandman PM. Explaining risk to non-experts: A communications challenge. Emerg Prep Dig 1987;14:25-92.
36.
37.
38.
Hendel RC, Cerqueira M, Douglas PS, et al. A multicenter assessment of the use of single-photon emission computed tomography myocardial perfusion imaging with appropriateness criteria. J Am Coll Cardiol 2010;55:156-62.PubMedCrossRef
39.
Brewer NT, Tzeng JP, Lillie SE, Edwards AS, Peppercorn JM, Rimer BK. Health literacy and cancer risk perception: Implications for genomic risk communication. Med Decis Making 2009;29:157-66.PubMedCrossRef
40.
Sharp LK, Zurawski JM, Roland PY, O’Toole C, Hines J. Health literacy, cervical cancer risk factors, and distress in low-income African-American women seeking colposcopy. Ethn Dis 2002;12:541-6.PubMed
41.
42.
Roter DL, Hall JA, Aoki Y. Physician gender effects in medical communication: A meta-analytic review. J Am Med Assoc 2002;288:756-64.CrossRef
43.
Helitzer DL, Lanoue M, Wilson B, de Hernandez BU, Warner T, Roter D. A randomized controlled trial of communication training with primary care providers to improve patient-centeredness and health risk communication. Patient Educ Couns 2010;82:21-9.PubMedCrossRef
44.
Roter DL, Hall JA. Communication and adherence: Moving from prediction to understanding. Med Care 2009;47:823-5.PubMedCrossRef
45.
Ghods BK, Roter DL, Ford DE, Larson S, Arbelaez JJ, Cooper LA. Patient-physician communication in the primary care visits of African Americans and whites with depression. J Gen Intern Med 2008;23:600-6.PubMedCrossRef
46.
Young LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD study: A randomized controlled trial. J Am Med Assoc 2009;301:1547-55.CrossRef
47.
Jacob K, Vivian G, Steel JR. X-ray dose training: Are we exposed to enough? Clin Radiol 2004;59:928-34. discussion 6-7.PubMedCrossRef
48.
Quinn AD, Taylor CG, Sabharwal T, Sikdar T. Radiation protection awareness in non-radiologists. Br J Radiol 1997;70:102-6.PubMed
49.
Shiralkar S, Rennie A, Snow M, Galland RB, Lewis MH, Gower-Thomas K. Doctors’ knowledge of radiation exposure: Questionnaire study. BMJ 2003;327:371-2.PubMedCrossRef
Metadata
Title
Strategies for defining an optimal risk-benefit ratio for stress myocardial perfusion SPECT
Authors
Reza Fazel, MD, MSc
Vasken Dilsizian, MD
Andrew J. Einstein, MD, PhD
Edward P. Ficaro, PhD
Milena Henzlova, MD
Leslee J. Shaw, PhD
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 3/2011
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-011-9353-4

Other articles of this Issue 3/2011

Journal of Nuclear Cardiology 3/2011 Go to the issue

Editor's Page

Noninvasive cardiovascular imaging in primary prevention: Does it influence management and outcomes?

Original Article

The effect of ranolazine on the vasodilator-induced myocardial perfusion abnormality

Review Article

Assessment of coronary endothelial function using PET

Original Article

Myocardial substrate and route of administration determine acute cardiac retention and lung bio-distribution of cardiosphere-derived cells

News

Cme instructions: Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance

Editorial

Mobilizing the fountain of youth within

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits